Next Article 
Journal of Virology, November 1999, p. 8919-8925, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Characterization of Intracellular Reverse
Transcription Complexes of Moloney Murine Leukemia Virus
Ariberto
Fassati and
Stephen P.
Goff*
Department of Biochemistry and Molecular
Biophysics, Howard Hughes Medical Institute, Columbia University
College of Physicians and Surgeons, New York, New York 10032
Received 18 May 1999/Accepted 26 July 1999
 |
ABSTRACT |
To examine the early events in the life cycle of Moloney murine
leukemia virus (MoMLV), we analyzed the intracellular complexes mediating reverse transcription. Partial purification of the reverse transcription complexes (RTCs) by equilibrium density fractionation and
velocity sedimentation indicated that three distinct species of
intracellular complexes are formed shortly after cell infection. Only
one of these species is able to start and complete reverse transcription in the cell cytoplasm. This RTC is composed of at least
the viral genome, capsid, integrase, and reverse transcriptase proteins. The RTC becomes permeable to micrococcal nuclease but not to
antibodies. Shortly after initiation of reverse transcription, the
viral strong stop DNA within the RTC is protected from nuclease digestion. The sedimentation velocity of the RTC decreases during reverse transcription. After entry into the nucleus, most capsid proteins are lost from the RTC and its sedimentation velocity decreases further.
 |
INTRODUCTION |
All retroviruses synthesize a
double-stranded DNA copy of their RNA genome that is subsequently
integrated into the host cell chromosomal DNA. The process of reverse
transcription of the RNA genome into DNA is carried out in the
cytoplasm soon after viral penetration into the cell and is generally
completed within 8 to 12 h (30). Little is known about
the structure and the protein composition of the intracellular complex
in which reverse transcription occurs, particularly during the early
steps after virus internalization. In the murine leukemia virus (MLV),
the intracellular viral structure that contains the fully reverse
transcribed viral DNA (also called the preintegration complex [PIC])
retains components of the virion core (including CA protein), has a
relatively large size, sedimenting at 160S, and is competent to
integrate the DNA in vitro (5). The PIC of human
immunodeficiency virus type 1 (HIV-1) appears to have a different
organization since it contains no capsid proteins, but it contains at
least reverse transcriptase (RT), integrase (IN), and a portion of
matrix (MA) proteins (6, 9, 16, 23). In addition, two
cellular proteins have been found to associate with the PIC. They
increase the efficiency of integration of the viral genome in vitro
(10) and/or prevent self-integration of the viral DNA, which
would result in an nonproductive infection (17).
MLVs are widely used as vectors for gene therapy because of their
relatively simple genome organization and their ability to infect a
wide variety of cell types and integrate DNAs into the host cell genome
(21). However, a major limitation of MLV-based vectors is
their inability to infect nondividing cells (18, 22, 28), as
opposed to vectors based on lentiviruses (24). The reasons
for the inability of MLV-based vectors to infect nondividing cells are
uncertain; the large size of their PIC or the lack of appropriate
nuclear targeting signals may be responsible. A more detailed knowledge
of the organization of the intracellular viral complex in which reverse
transcription occurs would improve our understanding of the
interactions between the incoming virus and the infected cells. It may
also allow the design of new MLV-based vectors in which the reverse
transcription complex (RTC) is targeted to the nucleus of nondividing
cells. To characterize the dynamics of the early steps of virus life
cycle, we have analyzed detergent-free cytoplasmic and nuclear extracts
at various time points after acute infection. These studies revealed
the existence of three distinct species of intracellular complexes. Two
species are incompetent for reverse transcription in vivo, while a
third species starts and completes reverse transcription in the cell cytoplasm.
 |
MATERIALS AND METHODS |
Cells and viruses.
The retroviral vector LNPOZ (kind gift of
A. D. Miller, Fred Hutchinson Cancer Research Center, Seattle,
Wash.) contains the neomycin phosphotransferase and lacZ
genes separated by the poliovirus ribosome entry site (1).
NIH 3T3 mouse fibroblasts and the producer cell clone AmpliGPE LNPOZ
(11, 12) were grown in 175-cm2 flasks in
Dulbecco's modified Eagle's medium supplemented with 2 mM glutamine
and 10% fetal calf serum at 37°C in an atmosphere containing 5%
CO2. Culture medium was replaced when cells reached confluence; the virus-containing supernatant was collected 16 to
18 h later and filtered through a 0.45-µm-pore-size filter. Viral titers were determined by infecting NIH 3T3 cells with serial dilutions of virus containing supernatant in the presence of 8 µg of
polybrene per ml. Approximately 36 h after infection, cells were
fixed in 0.5% glutaraldehyde in phosphate-buffered saline (PBS)
containing 1 mM MgCl2 for 10 min at room temperature and stained 8 to 10 h with
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-Gal)
at 37°C in an humidified atmosphere (19).
Cell extracts.
Approximately 107 NIH 3T3
fibroblasts were infected in 175-cm2 flasks with 30 ml of
freshly collected virus-containing supernatant (3 × 106 CFU/ml) in the presence of 8 µg of polybrene per ml.
Infected cells were rapidly cooled to 4°C and incubated for 2 h
to allow viral adhesion to the cell receptor but not viral
internalization. Cells were then incubated at 37°C for 1, 2, 4, 7, and 16 h, washed once in PBS-0.5 mM EDTA, trypsinized, and washed
once again with PBS. All subsequent manipulations were carried out at
4°C. The pellet containing the infected cells was resuspended in 5 volumes of hypotonic buffer (10 mM HEPES [pH 7.9], 1.5 mM
MgCl2, 10 mM KCl, 5 mM, dithiothreitol [DTT], 20 µg of
aprotinin per ml, 2 µg of leupeptin per ml) and centrifuged for 5 min
at 5,000 rpm in an Eppendorf model 5415C centrifuge. The pellet was
resuspended in 3 volumes hypotonic buffer and incubated for 10 min.
Cells were homogenized with 10 to 15 strokes in a Dounce homogenizer, and nuclei and unbroken cells were pelleted by centrifugation at
3,300 × g for 15 min (corresponding to 6,000 rpm in an
Eppendorf Microfuge). The supernatant (called the cytoplasmic extract)
was clarified by centrifugation at 7,500 × g for 20 min, and the pellet was discarded. The nuclear pellet from the previous
centrifugation was resuspended in approximately 600 µl of isotonic
buffer (10 mM Tris HCl [pH 7.4], 160 mM KCl, 5 mM MgCl2,
1 mM DTT, 20 µg of aprotinin per ml, 2 µg of leupeptin per ml) and
homogenized in a ball-bearing homogenizer. The homogenate was then
centrifuged at 7,500 × g for 20 min, and the
supernatant (called the nuclear extract) was collected. Nuclear and
cytoplasmic extracts were adjusted to 8% sucrose, snap frozen in
liquid N2, and stored at
70°C.
Equilibrium density gradients.
Continuous linear sucrose
gradients (5 ml) were poured with a two-chamber Hoefer SG gradient
maker, using 20% sucrose solution in hypotonic buffer and 70% sucrose
solution in D2O, and kept on ice. The pH of D2O
was adjusted to 7.4 by dropwise addition of 10 mM NaOH. Gradients were
overlaid with 0.5 ml of cytoplasmic or nuclear extracts and centrifuged
at 35,000 rpm at 4°C for 20 h in a Beckman SW55 rotor. For
analysis of the viral core, 1 ml of virus-containing supernatant was
treated with the indicated detergent for 30 min at room temperature
with gentle shaking. Treatment with ethyl ether (Baxter) was performed
for 20 min at 4°C. Samples were loaded onto a 20 to 60% continuous
sucrose gradients in 50 mM sodium phosphate buffer (pH 7.4) containing
2 mM DTT and centrifuged to equilibrium at 25,000 rpm for 20 h at
4°C in a Beckman SW41 rotor. Gradients were fractionated by
puncturing the bottom of the tube and collecting 12 fractions. The
density was calculated by weighing 100 µl of each fraction.
Sedimentation velocity gradients.
Continuous gradients were
poured as described above, using 5 and 20% sucrose solutions in 50 mM
sodium phosphate buffer (pH 7.4) containing 2 mM DTT, 20 µg of
aprotinin per ml, and 2 µg of leupeptin per ml. Approximately 150 µl of the equilibrium density fraction containing the peak of the
viral DNA was diluted with 1.2 ml of hypotonic buffer, loaded onto a
Centricon 50 concentrator (Amicon), and centrifuged at 4,000 × g for 30 min at 4°C in a Sorvall centrifuge. The concentrate
(50 µl) was resuspended in 300 µl of 50 mM sodium phosphate buffer,
loaded on a 5 to 20% continuous sucrose gradient, and centrifuged at
23,000 rpm for 1 h at 4°C in a Beckman SW55 rotor. Fractions
(0.4 ml each) were collected by puncturing the bottom of the tube, and
the density was measured by weighing 100 µl of each fraction. The S
value was calculated by the method of McEwen (20).
Calibration of the system was performed by independently running
32S-labeled poliovirus, intact MoMLV, and naked viral DNA
through identical sucrose gradients.
PCR.
PCR was performed in a final volume of 50 µl
containing 1× PCR buffer, 100 µM each deoxynucleoside triphosphate
(dNTP), 2.5 mM MgCl2, 5 U of Taq polymerase
(Perkin-Elmer), and 30 pmol of each primer. Primer sequences were as
follows: strong-stop forward primer, 5'-GCGCCAGTCTTCCGATAGAC-3';
strong-stop reverse complementary primer,
5'-AATGAAAGACCCCCGTCGTGG-3'; extended minus-strand forward primer, 5'-CACGACGCGCTGTATCGCTGG-3'; extended minus-strand
reverse complementary primer, 5'-CATACAGAAATGGCGATCGTTC-3';
plus-strand forward primer, 5'-GTGATTGACTACCCACGACG-3';
and plus-strand reverse complementary primer,
5'-GACCTTGATCTTAACCTGGG-3'. Five microliters of the
equilibrium density fractions or 1.5 µl of the sedimentation velocity
fractions was used as the template for the PCR. Cycle parameter were as
follows: 94°C for 3 min the first cycle; 94°C for 1 min, 55°C for
30 s, and 68°C for 1 min for 35 to 45 cycles; and one final
extension cycle at 68°C for 10 min. PCR products were resolved on a
1% agarose-2% NuSieve gel and visualized by ethidium bromide
staining. Semiquantitative PCR was performed in duplicate in the same
conditions as described above, using threefold serial dilutions of the
DNA template. The number of cycles was adjusted in each individual
experiment to ensure linearity of amplification. Following
amplification, the bands were resolved on a 1% agarose-2% NuSieve
gel, visualized by ethidium bromide staining, and quantified by a
Molecular Dynamics 300A densitometer.
Antibodies and Western blotting.
Goat polyclonal antibodies
against MLV whole virus (81S000044) and against MLV CA protein
(79S-804) were from the national Cancer Institute (Frederick, Md.).
Rabbit polyclonal antibodies against MLV RT were as described
previously (3). Chicken polyclonal antibodies against
Moloney MLV (MoMLV) IN were raised against the multiple antigenic
peptide
HO - Ala - Lys7 - N - (C - L - T - W - R - V - Q - R - S - Q - N - P - L - K - I - R - L - T - R - E - A - P)8
(26), which corresponds to the last 21 amino acids of
the MoMLV IN (34). Chicken immunization was performed by
Gallina Biotechnology Inc. (Edmonton, Alberta, Canada). Briefly, 300 µg of peptide diluted in 100 µl of PBS was injected into two chickens in the presence of Freund's adjuvant. Chickens were injected three times at 4-week intervals. Eggs were collected 4 weeks after the
last injection, and antibodies were purified from the yolks by
precipitation in 12% polyethylene glycol 8000 according to the method
of Polson et al. (25). Purified antibodies were stored at
70°C in the presence of 0.01% sodium azide. For Western blot analyses, 300 µl of each fraction from the density equilibrium sucrose gradients was diluted in 1.2 ml of ice-cold 50 mM sodium phosphate buffer (pH 7.4) in the presence of 2 µg of bovine serum albumin (Sigma) and 10% (vol/vol) trichloroacetic acid. Fractions were
incubated at
20°C for 16 h and centrifuged for 30 min at 4°C
at maximum speed in an Eppendorf Microfuge. The pellets were washed
once in a solution of ice-cold 80% acetone in distilled H2O and resuspended in 20 µl of sodium dodecyl sulfate
(SDS) loading buffer (0.5 M Tris HCl [pH 6.8], 1% SDS, 10%
glycerol, 0.1% bromophenol blue, 1 mM EDTA, 10 mM DTT, 20 µg of
aprotinin per ml, 2 µg of leupeptin hemisulfate per ml, 10 µg of
phenylmethylsulfonyl fluoride). The pH was adjusted to ~7.0 by
addition of 1 µl of 1.5 M Tris HCl (pH 8.8). Samples were boiled for
5 min and loaded on an SDS-12.5% polyacrylamide gel. After
electrophoresis, the proteins were transferred to a polyvinylidene
difluoride membrane (Bio-Rad, Hercules, Calif.) and probed with the
goat antiserum diluted 1:5,000 or with the chicken polyclonal antibody
against MLV IN diluted 1:1,000. Horseradish peroxidase-conjugated
secondary antibodies were used diluted 1:10,000 (anti-goat; Boehringer
Mannheim) or 1:6,000 (anti-chicken; Promega) in 10% nonfat milk
(Nestlé, Glendale, Calif.). Enhanced chemiluminescence (ECL-Plus;
Amersham) was used to develop the blots as described by the
manufacturer. Autoradiography films were exposed for different periods
of time to ensure linearity of the signal and then analyzed by a
Molecular Dynamics 300A densitometer.
Assays for reverse transcription.
To test for the ability of
the rabbit polyclonal antibodies against MoMLV RT to inhibit RT
activity, twofold serial dilutions of purified protein (1 ng to 0.3 ng)
were incubated in the presence of antiserum or preimmune serum diluted
1:100 and 1:200 in PBS for 30 min at room temperature. Reverse
transcriptase activity was then tested with the oligo(dT)-poly(rA)
assay as previously described (14, 31). Briefly, 10 µl of
samples was added to 40 µl of RT cocktail {60 mM Tris HCl (pH 8.0),
180 mM KCl, 6 mM MnCl2, 6 mM DTT, 0.05% Nonidet P-40, 6 µg of oligo(dT) per ml, 12 µg of poly(rA) per ml, 0.05 mM
[
32]dTTP (800 Ci/mmol} for 1 h at 37°C.
Samples were spotted onto DE-81 paper and washed three times with 2×
SSC (0.3 M NaCl plus 0.03 M sodium citrate). A PhosphorImager
(Molecular Dynamics, Sunnyvale, Calif.) was used to quantitate the
radioactivity incorporated. Endogenous reverse transcription reactions
were carried out in 60 µl of buffer (50 mM Tris-HCl [pH 8.3], 50 mM
NaCl, 6 mM MgCl2, 0.01% Nonidet P-40, 1 mM DTT, 2 mM each
dNTP). Fifteen-microliter aliquots from the density equilibrium
fractions were added to the buffer and incubated for 4 to 6 h at
37°C. The products of reverse transcription were detected by PCR
using 5 µl of the endogenous reaction as the template. To test for
the ability of the rabbit antisera against MoMLV RT to inhibit RT
activity in the endogenous assay, samples were incubated as described
above in the presence of either antiserum or preimmune serum diluted
1:100 and 1:200. After 4 to 6 h incubation at 37°C, serial
dilutions of the samples were subjected to semiquantitative PCR to
detect the product of reverse transcription.
Nuclease treatments.
All nuclease treatments were performed
in 25 µl of isotonic buffer (1 mM DTT, 20 µg of aprotinin per ml, 2 µg of leupeptin hemisulfate per ml, 7 U of S7 micrococcal nuclease
[Boehringer Mannheim], 2 mM CaCl2). Five-microliter
aliquots from those equilibrium density fractions containing the peak
of the retroviral DNA were added to the nuclease mixture, and samples
were incubated on ice. The reaction was stopped by addition of 4 mM
EGTA and kept on ice. Two aliquots of 5 µl each from the same
reaction were analyzed by semiquantitative PCR with strong-stop and
extended minus-strand primers. The nuclease sensitivity of the intact
RTCs was compared with that of naked viral DNA. Control digests of
naked viral DNA were carried out in the presence of 5-µl aliquots
from equilibrium density fractions containing cytoplasmic extracts from
uninfected NIH 3T3 fibroblasts and having the same density as the
fractions containing the RTCs.
 |
RESULTS |
Disruption of virion cores by detergents.
Low yields of MoMLV
cores can be released from intact virions by treatment with detergents,
and the lipid-stripped core can then be separated from the virions by
equilibrium density centrifugation on the basis of its higher density
(4, 8). To test whether such protocols could be modified to
permit efficient recovery of virion cores, virions were treated with a
variety of detergents and then subjected to equilibrium density
centrifugation through continuous sucrose gradients. The gradients were
fractionated, and individual fractions were analyzed by both PCR (to
detect the viral genome) and Western blotting (to detect viral Gag
proteins). Untreated virions sedimented at a density of 1.16 g/ml
(Table 1). Most detergents disrupted the
virions, as indicated by the presence of >90% of the
p30gag CA in the top fractions of the gradient.
Treatment with low doses of some detergents resulted in the recovery of
the immature Pr65gag at a density of 1.25 ± 0.017 g/ml, consistent with the density of the MLV core (4,
8). However, cores containing mature CA could never be recovered
at densities higher than 1.16 g/ml. Thus, treatment of MoMLV with
detergents at concentrations sufficient to remove the lipids could
release intact immature cores composed of uncleaved
Pr65gag but disrupted the mature core composed
of p30gag CA. These results suggested that
intracellular complexes might also be disrupted by detergents and
should instead be isolated by hypotonic breakage of the cell membrane
and Dounce homogenization.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Distribution of Gag proteins after equilibrium density
fractionation of virions treated with
different detergentsa
|
|
Extraction of the MoMLV RTC in hypotonic buffer.
To prepare
the RTC, NIH 3T3 fibroblasts were infected with an ecotropic
MoMLV-based vector (11, 12) at a multiplicity of infection
of 10. Infection was synchronized by preincubating the cells for 2 h at 4°C to allow for virus binding to the receptor. Cells were lysed
by hypotonic breakage of the cell membrane and Dounce homogenization
(see Materials and Methods). Control extractions performed in the
presence of SDS indicated that approximately 60 to 70% of total viral
DNA could be extracted by this method. Cytoplasmic extracts were
prepared 1, 2, 4, 7, and 16 h postinfection, and nuclear extracts
were prepared 7 and 16 h postinfection. The cell extracts were
subjected to equilibrium density sedimentation, and the fractions were
analyzed by PCR and Western blotting. The viral strong-stop DNA, which
is the earliest product of reverse transcription, could be detected as
a discrete peak at a density of 1.35 g/ml, consistent with the density
of a nucleoprotein complex (Fig. 1). The
strong-stop DNA was found at the same density in cytoplasmic and
nuclear extracts, and this density did not change significantly with
time (Table 2). Viral CA proteins were
distributed over a wide density range in cytoplasmic extracts obtained
1 h after infection. At later time points, CA proteins were found distributed in two discrete peaks of 1.35 and 1.12 g/ml (Fig. 1). The
1.35-g/ml peak containing CA proteins consistently cofractionated with
the strong-stop DNA, and the quantity of CA in this peak reached a
maximum 7 h postinfection. Trace amounts of CA cofractionated with
the strong-stop DNA in the nuclear extracts collected 7 h after
infection (Fig. 1). Semiquantitative PCR analyses indicated that 7 h after infection, the quantity of strong-stop DNA in the peak
fractions from the nuclear extracts was approximately 1/3 of that of
cytoplasmic extracts, while the quantity of CA cofractionating with the
strong-stop DNA in nuclear extracts was approximately 1/10 of that of
cytoplasmic extracts (not shown). This finding suggested that most CA
proteins were lost from the complex after entry into the cell nucleus.
Neither the strong-stop DNA nor CA proteins were detected in
equilibrium density gradients containing extracts from uninfected cells
(not shown).

View larger version (93K):
[in this window]
[in a new window]
|
FIG. 1.
PCR and Western blot analyses of cytoplasmic and nuclear
extracts after equilibrium density fractionation. NIH 3T3 fibroblasts
were infected with a MoMLV-based vector; cell extracts were prepared 1, 2, 4, and 7 h postinfection, loaded on a 20 to 70% linear sucrose
gradient, and centrifuged at 4°C for 20 h at 35,000 rpm in a
Beckman SW55 rotor. After centrifugation, gradients were collected in
12 fractions and analyzed. Arrows indicate the direction of the
gradient from the lowest (top) to the highest (bottom) density. (A) PCR
analyses of the equilibrium density fractions using primers specific
for the strong-stop DNA (expected band size is 145 bp). The density of
the fraction containing the peak of the viral DNA is indicated for each
time point. MW, DNA molecular weight standards. Lanes 1 to 12 correspond to fractions 1 to 12. The rapidly migrating bands are PCR
artifacts. (B) The same fractions were precipitated in 10%
trichloroacetic acid and analyzed by Western blotting using goat
polyclonal antibodies against whole MLV. Purified virus (Virus) and
infected NIH 3T3 cells (3T3+) were used as positive controls.
Uninfected 3T3 cells (3T3 ) were used as negative controls.
|
|
Equilibrium density fractions containing cytoplasmic and nuclear
extracts were analyzed by Western blotting to detect the presence of
IN. A peak of CA and IN was found to cofractionate at the same buoyant
density of the strong-stop DNA (1.35 g/ml) (Fig.
2). The CA/IN ratio in the cytoplasmic
extracts was higher than in the nuclear extracts, reinforcing the view
that most CA proteins were lost from the RTC after entry into the cell
nucleus (Fig. 2).

View larger version (83K):
[in this window]
[in a new window]
|
FIG. 2.
Western blot analyses of equilibrium density fractions
containing cytoplasmic extracts collected 4 h postinfection (A) or
nuclear extracts collected 7 h postinfection (B). Following
SDS-polyacrylamide gel electrophoresis and protein transfer, the
polyvinylidene difluoride membrane was probed with the goat polyclonal
antibodies against MLV CA or the chicken polyclonal antibodies against
MoMLV IN. Lane 1, purified virus; lane 2, uninfected NIH 3T3 cells;
lane 3, infected NIH 3T3 cells before equilibrium density
fractionation; lane 4, molecular weight standards; lanes 5 to 16, fractions 1 to 12 of the density gradient. The arrow indicates the
direction of the gradient from the lowest (top) to the highest (bottom)
density.
|
|
Ability of the RTCs to synthesize DNA.
To evaluate whether the
fractions containing the strong-stop DNA also contained elongated
reverse transcription products, aliquots from the same fractions were
subjected to PCR, using primers specific for the viral elongated
minus-strand DNA and for the plus-strand DNA, which represent
intermediate and late reverse transcription products, respectively. As
shown in Fig. 3, the elongated minus
strand could be detected 2 h after cell infection, and its
quantity increased 4 h after infection. The plus strand could be
detected only 7 h after infection, and it was 20-fold less
abundant than the elongated minus strand, as determined by
semiquantitative PCR. This finding suggested that reverse transcription
was not completed in a large number of RTCs.

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 3.
PCR analyses of equilibrium density fractions containing
cell extracts collected 1, 2, 4, and 7 h postinfection. (A)
Selected fractions from the same equilibrium density gradients shown in
Fig. 1 were subjected to PCR using primers specific for the viral
elongated minus-strand DNA (expected band size is 437 bp). Fraction
numbers are the same as in Fig. 1. Naked viral DNA was used as a
positive control (ctr+), and one reaction contained no viral DNA
template (ctr ). (B) Fraction 3 of the density gradient containing the
nuclear extracts (nuc 3) and fraction 2 of the density gradient
containing the cytoplasmic extracts (cyt 2) were subjected to PCR using
primers specific for the viral plus-strand DNA (expected band size is
700 bp). Fraction numbers are the same as in Fig. 1. Naked viral DNA
was used as a positive control (ctr+), and one reaction contained no
viral DNA template (ctr ). The rapidly migrating bands are PCR
artifacts.
|
|
To test which of these complexes were competent to carry out reverse
transcription in vitro, we performed an endogenous reverse transcription assay on 10-fold dilutions of the equilibrium density fractions containing the peak of the strong-stop DNA. The endogenous reverse transcription assay examines not only polymerase activity but
also the integrity of the reverse transcription machinery and its
ability to synthesize full-length viral DNA. Samples were incubated at
37°C in the presence or absence of 0.01% Nonidet P-40, and aliquots
from the reactions were subjected to PCR using primers specific for the
elongated minus strand and for the plus strand. No elongated reverse
transcription product was detectable in the absence of exogenous dNTPs
(Fig. 4). The amount of elongated minus
strand increased progressively in the cytoplasmic extracts collected 1, 2, and 4 h after infection but decreased at 7 h after infection, perhaps because of partial intracellular degradation of the
RTCs. Similarly, the maximum amount of the plus strand was detected in
the fractions of the cell extracts collected 4 h after infection.
The presence of Nonidet P-40 increased the efficiency of the endogenous
reverse transcription assay; controls showed that it did not affect
either the efficiency of the PCR or the activity of purified MoMLV RT
(not shown). Thus, the complexes sedimenting at 1.35 g/ml are competent
for DNA synthesis.

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 4.
Endogenous reverse transcription assay of equilibrium
density fractions containing the peak of viral DNA from cytoplasmic
extracts collected 1, 2, 4, and 7 h postinfection. Samples diluted
1:10 were incubated with exogenous dNTPs for 6 h at 37°C in the
presence (+) or absence ( ) of Nonidet P-40 and then subjected to PCR
with primers specific for the elongated minus-strand [( ) strand]
DNA (expected band size is 437 bp) or the plus-strand [(+) strand]
DNA (expected band size is 700 bp). An aliquot of the same fractions
was incubated in the absence of dNTPs (no dNTPs). Some samples
contained the same amount of cytoplasmic extracts from uninfected cells
(ctr ). The rapidly migrating bands are PCR artifacts.
|
|
Different species of RTC are found after viral entry into the
cells.
Western blot analysis of the equilibrium density fractions
containing the cytoplasmic extracts from infected cells showed small
amounts of viral CA proteins distributed over a wide density range.
Nevertheless, the viral DNA was found in a single discrete peak (Fig.
1). We reasoned that some of the fractions containing CA proteins might
also have contained the viral RNA genome which could not be detected by
standard PCR. Therefore, an endogenous reverse transcription assay was
performed on fractions from the density gradients containing the
cytoplasmic extracts collected 1 and 4 h after infection. As shown
in Fig. 5, strong-stop DNA was now
detectable in some of those fractions which scored negative in previous
assays (compare Fig. 1 with Fig. 5). In particular, the elongated minus
strand could be detected in the lower-density shoulder of the main peak
seen previously (Fig. 1). These fractions have a buoyant density near
1.32 g/ml and thus are lighter than the preexisting DNA found at 1.34 to 1.36 g/ml. This finding suggested that different species of RTC
existed which were unable to start reverse transcription after viral
entry into the cells. Some of these RTCs had a relatively high density
(approximately 1.32 g/ml) and were able to synthesize the elongated
minus strand DNA upon incubation with exogenous dNTPs and Nonidet P-40.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 5.
Endogenous reverse transcription assay of equilibrium
density gradient fractions containing cytoplasmic extracts collected 1 and 4 h postinfection. Aliquots of the density gradients fractions
were incubated at 37°C for 4 h in the presence of dNTPs and
Nonidet P-40 and then analyzed by PCR using primers specific for the
strong-stop DNA (top; expected band size is 145 bp) or the elongated
minus-strand DNA (bottom; expected band size is 437 bp). (A) MW, DNA
molecular weight standards; lanes 4 to 11, fractions 4 to 11 of the
gradient shown in Fig. 1. (B) Lanes 5 to 12, fractions 5 to 12 of the
gradient shown in Fig. 1; mw, DNA molecular weight standards; lane 13, virus subjected to the endogenous reverse transcription assay; lane 14, virus incubated in the absence of dNTPs. Naked DNA was used as positive
control for amplification of the elongated minus-strand DNA (ctr+). One
reaction contained no viral DNA template (ctr ). The rapidly migrating
bands are PCR artifacts.
|
|
The size of the RTC changes during reverse transcription.
To
determine whether there were changes in the size of the RTC with a
buoyant density of 1.35 g/ml during reverse transcription, we subjected
partially purified RTCs to velocity sedimentation through linear
sucrose gradients. The equilibrium density fractions containing the
peak of the viral DNA were dialyzed and concentrated by passage through
a Centricon filter. The concentrate was then analyzed by sedimentation
velocity, and the position of the viral DNA in the gradients was
detected by PCR. In the cytoplasmic extracts, two discrete peaks with
sedimentation velocities of 560S and 380S to 340S were consistently
found 1, 2, and 4 h after infection. At later time points, a peak
with a sedimentation velocity of 270S to 220S also appeared (Fig.
6). The 220S to 270S species were always
less abundant than the 380S species. In the nuclear extracts, viral DNA
was distributed in all fractions, although three discrete peaks with a
sedimentation velocities of 560S, 180S, and 90S were consistently
observed (Fig. 6). If the cytoplasmic extracts were prepared in the
presence of 0.025% digitonin, a single RTC species was observed, and
its sedimentation velocity was reduced to about 150S, in good agreement
with previous reports (5). This suggested that RTC was
partially disrupted by treatment with low concentrations of digitonin.

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 6.
Analysis of RTCs by sedimentation velocity. Cytoplasmic
extracts collected 1, 2, 4, 7, and 16 h postinfection and nuclear
extracts collected 7 h postinfection were subjected to equilibrium
density centrifugation. Fractions containing the peak of retroviral DNA
were further purified and concentrated in a Centricon filter and
centrifuged through a 5 to 20% linear sucrose gradient for 1 h at
23,000 rpm in a Beckman SW55 rotor. Twelve fractions were collected,
and the viral DNA in each fraction was detected by PCR using primers
specific for the strong-stop DNA (expected band size is 145 bp). The
rapidly migrating bands are PCR artifacts.
|
|
The RTC is permeable to small but not to large macromolecules.
To evaluate the permeability of the RTC to macromolecules, we assayed
the sensitivity to micrococcal nuclease of the viral DNA within the
RTCs collected at various time points after cell infection. The
equilibrium density fractions from cytoplasmic extracts containing the
peak of the viral DNA were treated with micrococcal nuclease, and the
reaction was stopped at the time point indicated in Fig.
7 by addition of EGTA. Nuclease-treated samples were then analyzed by PCR with primers specific for the strong-stop DNA and for the elongated minus-strand DNA, respectively. When naked viral DNA was treated with micrococcal nuclease, the strong-stop DNA appeared more sensitive to digestion than the minus-strand DNA. However, when the viral DNA within the RTC was tested
for nuclease sensitivity, the strong-stop DNA was almost completely
protected, while the minus-strand DNA was digested (Fig. 7). We also
tested the ability of rabbit antiserum against MoMLV RT to inhibit
reverse transcription of the viral genome within the RTC. This
antiserum was able to inhibit the activity of purified RT about
10-fold, as detected by the oligo(dT)-poly(rA) assay (not shown).
Equilibrium density fractions containing the peak of the viral DNA were
subjected to endogenous reverse transcription assay in the presence of
the antiserum or rabbit preimmune serum. Samples were then analyzed by
semiquantitative PCR using primers specific for the plus-strand DNA.
The antiserum was unable to inhibit reverse transcription of the viral
genome in the RTC collected 1, 4, and 7 h after cell infection
(not shown). The same antiserum was able to immunoprecipitate purified
RT but was unable to immunoprecipitate RT in the RTC collected 7 h
after cell infection (not shown). These data indicated that the RTC was
permeable to small macromolecules like micrococcal nuclease but not to
larger macromolecules like immunoglobulin G antibodies.

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 7.
The viral strong-stop DNA in the RTC is protected from
micrococcal nuclease digestion. Equilibrium density fractions
containing the peak of the viral DNA from the cytoplasmic extracts
collected 1, 4, and 7 h postinfection were incubated on ice in the
presence of micrococcal nuclease and 2 mM CaCl2. The
reactions were stopped by addition of 4 mM EGTA at the indicated time
points and analyzed by PCR using primers specific for the strong-stop
DNA (expected band size is 145 bp) or for the elongated minus-strand
DNA (expected band size is 437 bp). Intact virions (CTR virus)
incubated in the presence of micrococcal nuclease were used as a
negative control. Naked viral DNA was incubated as described above in
the presence of micrococcal nuclease and cytoplasmic extracts from
uninfected cells (Hirt DNA). The fast-migrating bands are PCR
artifacts. To ensure the linearity of amplification, the samples were
subjected to two independent amplification rounds of 30 and 40 cycles,
respectively.
|
|
 |
DISCUSSION |
In this study we have analyzed the dynamics of the MoMLV RTC from
shortly after virus internalization to completion of reverse transcription and entrance into the cell nucleus. Analysis of the
cytoplasmic extracts indicated that at least three different species of
RTC are formed upon viral entry into the cells. All species appeared to
contain at least the viral genome, CA proteins, and RT as detected by
Western blotting, PCR, and endogenous reverse transcription assays. One
RTC species had a buoyant density of approximately 1.12 g/ml, which is
lower than the density of intact virions (13), and was
unable to start reverse transcription, although it could synthesize
strong-stop DNA if exogenous dNTPs and Nonidet P-40 were provided. A
second RTC species fractionated at a density of 1.32 g/ml, contained
RNA but no DNA, and was able to synthesize at least the minus-strand
DNA in vitro in the presence of added dNTPs and Nonidet P-40. A third
type of RTC fractionated at a density of 1.35 g/ml and contained both
minus- and plus-strand DNAs, indicating that it was competent for
reverse transcription. We suggest that the RTC with a buoyant density
of 1.12 g/ml was associated with membranes and may or may not be on a
productive pathway. The RTC with a buoyant density of 1.32 g/ml must be
free of most lipids, but its lack of DNA suggests that it may not be functional. Nevertheless, this RTC could synthesize the minus-strand DNA in the endogenous reverse transcription assay. The RTC with a
buoyant density of 1.35 g/ml contained the partially reverse transcribed viral genome, CA proteins, RT, and IN. This fraction presumably contained functional RTCs. This RTC species was also found
in the nuclear extracts. Western blot analyses after equilibrium density fractionation showed that much of the CA protein was lost from
the nuclear RTCs and that the CA/IN ratio of the cytoplasmic RTCs was
higher than that of the nuclear RTCs. Most of the RTCs with a density
of 1.35 g/ml did not contain the plus-strand DNA, even 16 h after
infection. They were nevertheless able to synthesize this DNA in an
endogenous reverse transcription assay, indicating that the structure
of the RTCs was well preserved. These data are consistent with the
possibility that this RTC is not very permeable to dNTPs in vivo.
The size of the RTC species with a density of 1.35 g/ml appeared to
change with time. At early stages after infection, two species with
sedimentation velocities of 560S and 380S were found. At later stages,
a complex with a sedimentation velocity of 280S to 220S was also
observed. In the nuclear extracts, three species with sedimentation
velocities of 560S, 180S, and 90S were found consistently. These RTCs
with different sedimentation velocities may represent discrete steps of
uncoating which take place in the cell cytoplasm and nucleus. The
results suggest the existence of an organized dissociation process of
the RTC which occurs during reverse transcription. CA proteins are
probably a major component which is lost during the process of
uncoating of the RTC. CA proteins are almost completely lost from the
PIC after entry into the nucleus, correlating with the lower
sedimentation velocity observed in the RTCs isolated from nuclear
extracts. The presence of CA in the RTCs may explain genetic and
structural findings which support the involvement of CA protein in
early steps of the viral life cycle. Indeed, mutants altered in CA
often produce normal levels of virions but are unable to initiate
reverse transcription in infected cells (15, 27, 29).
Fv1 restriction in mouse cells, which blocks infection
during the early stages, depends on specific sequences in the CA
protein of MLV (7).
The reverse transcription-competent RTC was found to be permeable to
small macromolecules like micrococcal nuclease but not to large ones
like antibodies. This structural constraint may be advantageous for the
completion of the viral life cycle, preventing dilution of RT and other
factors in the cytoplasm but allowing dNTPs and other small cell
proteins to enter the RTC. Treatment of the reverse
transcription-competent RTC with micrococcal nuclease showed that the
strong-stop DNA is almost completely protected from digestion whereas
the minus-strand DNA is not. After completion of DNA synthesis, the DNA
ends appear to form a large nucleoprotein complex called the intasome
(32, 33). Our data showed that the strong-stop DNA is
already protected 1 h after cell infection, indicating that the
intasome may be at least partially organized early during the viral
life cycle, well before reverse transcription is completed. It is not
clear whether the two RTC species with buoyant densities of 1.12 and
1.32 g/ml represent functional intermediates or totally defective
complexes. We suggest that they may be defective complexes arrested in
intermediate steps of the uncoating process since they did not contain
viral DNA even 4 h after infection. The system provided here may
allow analysis of the RTCs from a variety of viral mutants defective in
specific steps of the viral life cycle as well as cell mutants unable
to sustain productive infection, thus helping to clarify many important
issues related to the interactions between virus and cells.
 |
ACKNOWLEDGMENTS |
We are grateful to Marianna Orlova for advice and purified MoMLV
RT, to Brian McDermott for preparing 32S-labeled
poliovirus, and to Bernard Erlanger for advice on antibody peptide
design. We are thankful to Eran Bacharach, Guanxia Gao, Jason Gonsky,
and David Lim for advice and helpful discussions.
A.F. is a Wellcome Trust International Prize Research Fellow. S.P.G. is
an Investigator of the Howard Hughes Medical Institute.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry & Molecular Biophysics, Howard Hughes Medical Institute, Columbia University College of Physicians & Surgeons, 701 W. 168th St.,
New York, NY 10032. Phone: (212) 305-3794. Fax: (212) 305-8692. E-mail:
goff{at}cuccfa.ccc.columbia.edu.
 |
REFERENCES |
| 1.
|
Adam, M. A.,
N. Ramesh,
A. D. Miller, and W. R. A. Osborne.
1991.
Internal initiation of translation in retroviral vectors carrying picornavirus 5' nontranslated regions.
J. Virol.
65:4985-4990[Abstract/Free Full Text].
|
| 2.
|
Alin, K., and S. P. Goff.
1996.
Amino acid substitutions in the CA protein of Moloney murine leukemia virus that block early events in infection.
Virology
222:339-351[Medline].
|
| 3.
|
Blain, S. W., and S. P. Goff.
1993.
Nuclease activities of Moloney murine leukemia virus reverse transcriptase.
J. Biol. Chem.
268:23585-23592[Abstract/Free Full Text].
|
| 4.
|
Bolognesi, D. P.,
R. Luftig, and J. H. Sharper.
1973.
Localization of RNA tumor virus polypeptides.
Virology
56:549-564[Medline].
|
| 5.
|
Bowerman, B.,
P. O. Brown,
J. M. Bishop, and H. E. Varmus.
1989.
A nucleoprotein complex mediated the integration of retroviral DNA.
Genes Dev.
3:469-478[Abstract/Free Full Text].
|
| 6.
|
Bukrinsky, M. I.,
N. Sharova,
T. L. McDonald,
T. Pushkarskaya,
W. G. Tarpley, and M. Stevenson.
1993.
Association of integrase, matrix and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection.
Proc. Natl. Acad. Sci. USA
90:6125-6129[Abstract/Free Full Text].
|
| 7.
|
DesGroseillers, L., and P. Jolicoeur.
1983.
Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia virus.
J. Virol.
48:685-696[Abstract/Free Full Text].
|
| 8.
|
Durbin, R. K., and J. S. Manning.
1982.
The core of murine leukemia virus requires phosphate for structural stability.
Virology
116:31-39[Medline].
|
| 9.
|
Farnet, C. M., and W. A. Haseltine.
1991.
Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex.
J. Virol.
65:1910-1915[Abstract/Free Full Text].
|
| 10.
|
Farnet, C. M., and F. D. Bushman.
1997.
HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro.
Cell
88:483-492[Medline].
|
| 11.
|
Fassati, A.,
D. J. Wells,
F. S. Walsh, and G. Dickson.
1995.
Efficiency of in vivo gene transfer using murine retroviral vectors is strain dependent in mice.
Hum. Gene Ther.
6:1177-1183[Medline].
|
| 12.
|
Fassati, A.,
D. J. Wells,
F. S. Walsh, and G. Dickson.
1996.
Transplantation of retroviral producer cells for in vivo gene transfer into mouse skeletal muscle.
Hum. Gene Ther.
7:595-602[Medline].
|
| 13.
|
Fink, M. A.,
L. R. Sibal,
N. A. Wivel,
C. A. Cowles, and T. E. O'Conner.
1969.
Some characteristics of an isolated group antigen common to most strains of murine leukemia virus.
Virology
37:605-614[Medline].
|
| 14.
|
Goff, S. P.,
P. Traktman, and D. Baltimore.
1981.
Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.
J. Virol.
38:239-248[Abstract/Free Full Text].
|
| 15.
|
Hsu, H.-W.,
P. Schwartzberg, and S. P. Goff.
1985.
Point mutations in the p30 domain of the gag gene of Moloney murine leukemia virus.
Virology
142:211-214[Medline].
|
| 16.
|
Karageorgos, L.,
P. Li, and C. Burrell.
1993.
Characterization of HIV replication complexes early after cell-to-cell infection.
AIDS Res. Hum. Retroviruses
9:817-823[Medline].
|
| 17.
|
Lee, M. S., and R. Craigie.
1998.
A previously unidentified host protein protects retroviral DNA from autointegration.
Proc. Natl. Acad. Sci. USA
95:1528-1533[Abstract/Free Full Text].
|
| 18.
|
Lewis, P., and M. Emerman.
1994.
Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus.
J. Virol.
68:510-516[Abstract/Free Full Text].
|
| 19.
|
Lim, K., and C.-B. Chae.
1989.
A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase.
BioTechniques
7:576-579[Medline].
|
| 20.
|
McEwen, C. R.
1967.
Tables for estimating sedimentation through linear concentration gradients of sucrose solution.
Anal. Biochem.
20:114-149[Medline].
|
| 21.
|
Miller, A. D.
1992.
Human gene therapy comes of age.
Nature
357:455-460[Medline].
|
| 22.
|
Miller, D. G.,
M. A. Adam, and M. A. Miller.
1990.
Gene transfer by retroviruses vectors occurs only in cells that are actively replicating at the time of infection.
Mol. Cell. Biol.
10:4239-4242[Abstract/Free Full Text].
|
| 23.
|
Miller, M. D.,
C. M. Farnet, and F. D. Bushman.
1997.
Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition.
J. Virol.
71:5382-5390[Abstract].
|
| 24.
|
Naldini, L.,
U. Blomer,
P. Gallay,
D. Ory,
R. Mulligan,
F. H. Gage,
I. M. Verma, and D. Trono.
1996.
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.
Science
272:263-267[Abstract].
|
| 25.
|
Polson, A.,
T. Coetzer,
J. Kruger,
E. von Maltzahn, and K. J. van der Merwe.
1985.
Improvements in the isolation of IgY from the yolks of eggs laid by immunized hens.
Immunol. Investig.
14:323-327[Medline].
|
| 26.
|
Posnett, D. N.,
H. McGrath, and J. P. Tam.
1988.
A novel method for producing anti-peptide antibodies.
J. Biol. Chem.
263:1719-1725[Abstract/Free Full Text].
|
| 27.
|
Reicin, A.,
A. Ohagen,
L. Yin,
S. Hoglund, and S. P. Goff.
1996.
The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps in viral life cycle.
J. Virol.
70:8645-8652[Abstract].
|
| 28.
|
Roe, T.-Y.,
T. C. Reynolds,
G. Yu, and P. O. Brown.
1993.
Integration of murine leukemia virus DNA depends on mitosis.
EMBO J.
12:2099-2108[Medline].
|
| 29.
|
Schwartzberg, P.,
J. Colicelli,
M. L. Gordon, and S. P. Goff.
1984.
Mutations in the gag gene of Moloney murine leukemia virus: effects on production of virus and reverse transcriptase.
J. Virol.
49:918-924[Abstract/Free Full Text].
|
| 30.
|
Telesnitsky, A., and S. P. Goff.
1997.
Reverse transcriptase and the generation of retroviral DNA, p. 121-160.
In
J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 31.
|
Telesnitsky, A.,
S. Blain, and S. P. Goff.
1993.
Assays for retroviral reverse transcriptase.
Methods Enzymol.
262:347-362.
|
| 32.
|
Wei, S. Q.,
K. Mizuuchi, and R. Craigie.
1997.
A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration.
EMBO J.
16:7511-7520[Medline].
|
| 33.
|
Wei, S. Q.,
K. Mizuuchi, and R. Craigie.
1998.
Footprints on the viral DNA ends in Moloney murine leukemia virus preintegration complexes reflect a specific association with integrase.
Proc. Natl. Acad. Sci. USA
95:10535-10540[Abstract/Free Full Text].
|
| 34.
|
Weiss, R. A.,
N. Teich,
H. E. Varmus, and J. M. Coffin (ed.).
1985.
Molecular biology of tumor viruses: RNA tumor viruses, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
Journal of Virology, November 1999, p. 8919-8925, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Spidel, J. L., Wilson, C. B., Craven, R. C., Wills, J. W.
(2007). Genetic Studies of the {beta}-Hairpin Loop of Rous Sarcoma Virus Capsid Protein. J. Virol.
81: 1288-1296
[Abstract]
[Full Text]
-
Agarwal, S., Harada, J., Schreifels, J., Lech, P., Nikolai, B., Yamaguchi, T., Chanda, S. K., Somia, N. V.
(2006). Isolation, characterization, and genetic complementation of a cellular mutant resistant to retroviral infection. Proc. Natl. Acad. Sci. USA
103: 15933-15938
[Abstract]
[Full Text]
-
Puglia, J., Wang, T., Smith-Snyder, C., Cote, M., Scher, M., Pelletier, J. N., John, S., Jonsson, C. B., Roth, M. J.
(2006). Revealing Domain Structure through Linker-Scanning Analysis of the Murine Leukemia Virus (MuLV) RNase H and MuLV and Human Immunodeficiency Virus Type 1 Integrase Proteins. J. Virol.
80: 9497-9510
[Abstract]
[Full Text]
-
Wilhelm, M., Wilhelm, F.-X.
(2006). Cooperation between Reverse Transcriptase and Integrase during Reverse Transcription and Formation of the Preintegrative Complex of Ty1.. Eukaryot Cell
5: 1760-1769
[Abstract]
[Full Text]
-
Yu, J. H., Schaffer, D. V.
(2006). High-throughput, library-based selection of a murine leukemia virus variant to infect nondividing cells.. J. Virol.
80: 8981-8988
[Abstract]
[Full Text]
-
Hamamoto, S., Nishitsuji, H., Amagasa, T., Kannagi, M., Masuda, T.
(2006). Identification of a Novel Human Immunodeficiency Virus Type 1 Integrase Interactor, Gemin2, That Facilitates Efficient Viral cDNA Synthesis In Vivo.. J. Virol.
80: 5670-5677
[Abstract]
[Full Text]
-
Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I., Sodroski, J.
(2006). From the Cover: Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5{alpha} restriction factor. Proc. Natl. Acad. Sci. USA
103: 5514-5519
[Abstract]
[Full Text]
-
Dismuke, D. J., Aiken, C.
(2006). Evidence for a Functional Link between Uncoating of the Human Immunodeficiency Virus Type 1 Core and Nuclear Import of the Viral Preintegration Complex.. J. Virol.
80: 3712-3720
[Abstract]
[Full Text]
-
Passerini, L. D., Keckesova, Z., Towers, G. J.
(2006). Retroviral Restriction Factors Fv1 and TRIM5{alpha} Act Independently and Can Compete for Incoming Virus before Reverse Transcription. J. Virol.
80: 2100-2105
[Abstract]
[Full Text]
-
Jarrosson-Wuilleme, L., Goujon, C., Bernaud, J., Rigal, D., Darlix, J.-L., Cimarelli, A.
(2006). Transduction of Nondividing Human Macrophages with Gammaretrovirus-Derived Vectors. J. Virol.
80: 1152-1159
[Abstract]
[Full Text]
-
Yueh, A., Leung, J., Bhattacharyya, S., Perrone, L. A., de los Santos, K., Pu, S.-y., Goff, S. P.
(2006). Interaction of Moloney Murine Leukemia Virus Capsid with Ubc9 and PIASy Mediates SUMO-1 Addition Required Early in Infection. J. Virol.
80: 342-352
[Abstract]
[Full Text]
-
Bruce, J. W., Bradley, K. A., Ahlquist, P., Young, J. A. T.
(2005). Isolation of Cell Lines That Show Novel, Murine Leukemia Virus-Specific Blocks to Early Steps of Retroviral Replication. J. Virol.
79: 12969-12978
[Abstract]
[Full Text]
-
Vera, J., Parissi, V., Garcia, A., Zuniga, R., Andreola, M.-L., Caumont-Sarcos, A., Tarrago-Litvak, L., Leon, O.
(2005). Yeast system as a model to study Moloney murine leukemia virus integrase: expression, mutagenesis and search for eukaryotic partners. J. Gen. Virol.
86: 2481-2488
[Abstract]
[Full Text]
-
Yamashita, M., Emerman, M.
(2004). Capsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells. J. Virol.
78: 5670-5678
[Abstract]
[Full Text]
-
Narayan, S., Young, J. A. T.
(2004). Reconstitution of retroviral fusion and uncoating in a cell-free system. Proc. Natl. Acad. Sci. USA
101: 7721-7726
[Abstract]
[Full Text]
-
Zhu, K., Dobard, C., Chow, S. A.
(2004). Requirement for Integrase during Reverse Transcription of Human Immunodeficiency Virus Type 1 and the Effect of Cysteine Mutations of Integrase on Its Interactions with Reverse Transcriptase. J. Virol.
78: 5045-5055
[Abstract]
[Full Text]
-
Ostrow, K. M., Loeb, D. D.
(2004). Underrepresentation of the 3' Region of the Capsid Pregenomic RNA of Duck Hepatitis B Virus. J. Virol.
78: 2179-2186
[Abstract]
[Full Text]
-
Nermut, M. V., Fassati, A.
(2003). Structural Analyses of Purified Human Immunodeficiency Virus Type 1 Intracellular Reverse Transcription Complexes. J. Virol.
77: 8196-8206
[Abstract]
[Full Text]
-
Cheslock, S. R., Poon, D. T. K., Fu, W., Rhodes, T. D., Henderson, L. E., Nagashima, K., McGrath, C. F., Hu, W.-S.
(2003). Charged Assembly Helix Motif in Murine Leukemia Virus Capsid: an Important Region for Virus Assembly and Particle Size Determination. J. Virol.
77: 7058-7066
[Abstract]
[Full Text]
-
Onafuwa, A., An, W., Robson, N. D., Telesnitsky, A.
(2003). Human Immunodeficiency Virus Type 1 Genetic Recombination Is More Frequent Than That of Moloney Murine Leukemia Virus despite Similar Template Switching Rates. J. Virol.
77: 4577-4587
[Abstract]
[Full Text]
-
Wang, M. Q., Goff, S. P.
(2003). Defects in Virion Production Caused by Mutations Affecting the C-Terminal Portion of the Moloney Murine Leukemia Virus Capsid Protein. J. Virol.
77: 3339-3344
[Abstract]
[Full Text]
-
Suzuki, Y., Craigie, R.
(2002). Regulatory Mechanisms by Which Barrier-to-Autointegration Factor Blocks Autointegration and Stimulates Intermolecular Integration of Moloney Murine Leukemia Virus Preintegration Complexes. J. Virol.
76: 12376-12380
[Abstract]
[Full Text]
-
Yuan, B., Fassati, A., Yueh, A., Goff, S. P.
(2002). Characterization of Moloney Murine Leukemia Virus p12 Mutants Blocked during Early Events of Infection. J. Virol.
76: 10801-10810
[Abstract]
[Full Text]
-
Seamon, J. A., Jones, K. S., Miller, C., Roth, M. J.
(2002). Inserting a Nuclear Targeting Signal into a Replication-Competent Moloney Murine Leukemia Virus Affects Viral Export and Is Not Sufficient for Cell Cycle-Independent Infection. J. Virol.
76: 8475-8484
[Abstract]
[Full Text]
-
Serhan, F., Jourdan, N., Saleun, S., Moullier, P., Duisit, G.
(2002). Characterization of Producer Cell-Dependent Restriction of Murine Leukemia Virus Replication. J. Virol.
76: 6609-6617
[Abstract]
[Full Text]
-
Dirks, C., Miller, A. D.
(2001). Many Nonmammalian Cells Exhibit Postentry Blocks to Transduction by Gammaretroviruses Pseudotyped with Various Viral Envelopes, Including Vesicular Stomatitis Virus G Glycoprotein. J. Virol.
75: 6375-6383
[Abstract]
[Full Text]
-
Campbell, A. G.
(2001). Expression of Moloney Murine Leukemia Virus RNase H Rescues the Growth Defect of an Escherichia coli Mutant. J. Virol.
75: 6212-6217
[Abstract]
[Full Text]
-
Katen, L. J., Januszeski, M. M., Anderson, W. F., Hasenkrug, K. J., Evans, L. H.
(2001). Infectious Entry by Amphotropic as well as Ecotropic Murine Leukemia Viruses Occurs through an Endocytic Pathway. J. Virol.
75: 5018-5026
[Abstract]
[Full Text]
-
Fassati, A., Goff, S. P.
(2001). Characterization of Intracellular Reverse Transcription Complexes of Human Immunodeficiency Virus Type 1. J. Virol.
75: 3626-3635
[Abstract]
[Full Text]
-
Hameau, L., Jeusset, J., Lafosse, S., Coulaud, D., Delain, E., Unge, T., Restle, T., Le Cam, E., Mirambeau, G.
(2001). Human Immunodeficiency Virus Type 1 Central DNA Flap: Dynamic Terminal Product of Plus-Strand Displacement DNA Synthesis Catalyzed by Reverse Transcriptase Assisted by Nucleocapsid Protein. J. Virol.
75: 3301-3313
[Abstract]
[Full Text]
-
Cairns, T. M., Craven, R. C.
(2001). Viral DNA Synthesis Defects in Assembly-Competent Rous Sarcoma Virus CA Mutants. J. Virol.
75: 242-250
[Abstract]
[Full Text]
-
Snyder, C. S., Roth, M. J.
(2000). Comparison of Second-Strand Transfer Requirements and RNase H Cleavages Catalyzed by Human Immunodeficiency Virus Type 1 Reverse Transcriptase (RT) and E478Q RT. J. Virol.
74: 9668-9679
[Abstract]
[Full Text]
-
Bock, M., Bishop, K. N., Towers, G., Stoye, J. P.
(2000). Use of a Transient Assay for Studying the Genetic Determinants of Fv1 Restriction. J. Virol.
74: 7422-7430
[Abstract]
[Full Text]
-
Szurek, P. F., Brooks, B. R.
(2000). Synthesis of Virus-Specific High-Mobility DNA after Temperature Upshift of SC-1 Cells Chronically Infected with Moloney Murine Leukemia Virus Mutant ts1. J. Virol.
74: 7055-7063
[Abstract]
[Full Text]